Blood Transfusion - 1 2019 (January-February)
Further comments on "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis"
 
Authors:  Andrea Messori, Flora Peyvandi, Sabrina Trippoli, Roberta Palla, Frits R. Rosendaal, Pier Mannuccio Mannucci
Pages:  86
To cite this article:  Blood Transfus 2019; 17: 86
Doi:  10.2450/2017.0253-17
Published online:  22/12/2017

Preview
Dear Sir, 
The comments by Farrugia and Bansal1 on our article2 raise several points that deserve further discussion. One comment was that "the assumption that mortality would be unaffected between the two groups is challengeable"1, and a reference on this point was provided3. [...]
 
  
Full Text Download Back
       
Share this article: